Tumor lysis syndrome following docetaxel therapy for extensive metastatic protate cancer

Cancer Chemotherapy and Pharmacology

Volumn 54, Issue 2, 2004, Pages 191-192

  Sorscher, Steven M ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

Prostate cancer; Tumor lysis

Indexed keywords

ANTINEOPLASTIC AGENT; BICALUTAMIDE; DEXAMETHASONE; DOCETAXEL; MORPHINE; NAPROXEN; POLYSTYRENESULFONATE SODIUM;

AGED; ARTICLE; BONE METASTASIS; CANCER CELL; CANCER CHEMOTHERAPY; CASE REPORT; HEMATOLOGIC MALIGNANCY; HUMAN; HYPOTENSION; HYPOVOLEMIA; LABORATORY TEST; MALE; METASTASIS; PAIN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; TIME SERIES ANALYSIS; TUMOR LYSIS SYNDROME;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, PHYTOGENIC; HUMANS; MALE; PROSTATIC NEOPLASMS; TAXOIDS; TUMOR LYSIS SYNDROME;

EID: 3843078615     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Bishop MR, Coccia PF (1995) Tumor lysis syndrome. In: Abcloff MD, Armitage JO, Lichter AS, Niederhuber JE (eds) Clinical oncology. Churchill, New York, p 557
2. Drakos P, Bar-Ziv J, Catane R (1994) Tumor lysis syndrome in nonhematologic malignancies. Am J Clin Oncol 17:502-505
3. Baeksgaard L, Sorensen JB (2003) Tumor lysis syndrome-medulloblastoma. Cancer Chemother Pharmacol 51:187-192
4. Gravis G, Bladou F, Salem N, Macquart-Moulin G, Serment G, Carmerlo J, Genre D, Bardou VJ, Maranlnchl D, Viens P (2003) Weekly administration of docetaxel for symptomatic metastatic hormone-refractory prostate carcinoma. Cancer 98:1627-1634